#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Ataxia telangiectasia Neuroendocrine tumour Adenomatous polyposis coli IPEX syndrome Metabolic disorder Gastrointestinal neuroendocrine tumour Alveolar rhabdomyosarcoma Andersen-Tawil syndrome Huntington's disease Arrhythmia Acute myeloid leukaemia Bronchiolitis B-cell small lymphocytic lymphoma recurrent Skin angiosarcoma Gastrointestinal disorder More trials…

    Learn about Rare Diseases

    Alagille syndrome – Treatment Metachromatic leukodystrophy – Life with Disease Hyperoxaluria – Trials in Disease Proteus syndrome – Treatment Glomerulonephritis membranous – Diagnostics Lennox-Gastaut syndrome – Trials in Disease Niemann-Pick disease – Basic Information Glycogen storage disease type V – Basic Information Rhabdoid tumour – Treatment Propionic acidaemia – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Riociguat Histamine Hydrochloride Iclepertin Tretinoin Gozetotide ZINC Azd0305 Bifikafusp Alfa Sodium Hydrogen Carbonate Tamoxifen Etavopivat Treprostinil M1P Dipotassium Salt IDP-121 Gadoteric Acid Peppermint Oil Gen1046 DIMENHYDRINATE PRILOCAINE HYDROCHLORIDE Pentixather More therapies…

    Learn about Your Condition

    Malignant fibrous histiocytoma Peritoneal neoplasm Ocular melanoma Oesophageal carcinoma Optic ischaemic neuropathy Testicular germ cell cancer Dyspepsia Juvenile absence epilepsy Wolfram syndrome Vasoplegia syndrome Arterial stiffness Gender dysphoria Post-traumatic stress disorder T-cell type acute leukaemia Skin wrinkling More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study on the Effects of Escitalopram, Paroxetine, and Naltrexone for Patients with Compulsive Sexual Behavior Disorder

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Compulsive sexual behaviour
    Investigated Drugs:
    • Escitalopram Oxalate
    • Naltrexone Hydrochloride
    • Paroxetine
    Poland

  • Study on the Effects of Rapcabtagene Autoleucel in Patients with Systemic Lupus Erythematosus and Active, Refractory Lupus Nephritis

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Systemic lupus erythematosus
    • Lupus nephritis
    Investigated Drugs:
    • Voclosporin
    • Azathioprine
    • Belimumab
    Austria Czechia Denmark France Germany Hungary +7

  • Study on Teprenone for Preventing Atrial Fibrillation After Heart Surgery in Patients

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Atrial fibrillation
    Investigated Drugs:
    • Teprenone
    The Netherlands

  • Study of KYV-101 Therapy for Patients with Refractory Primary and Secondary Progressive Multiple Sclerosis

    Not yet recruiting

    2 1 1 1
    Investigated Drugs:
    • Kyv-101
    • Ocrelizumab
    • Ofatumumab
    Austria Belgium Germany Italy

  • Study on Acetylsalicylic Acid for Colorectal Cancer Patients with PI3K Pathway Mutations

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Colorectal cancer
    Investigated Drugs:
    • Acetylsalicylic Acid
    Denmark Finland Norway Sweden

  • Study comparing rapcabtagene autoleucel and rituximab in patients with severe refractory diffuse cutaneous systemic sclerosis

    Not yet recruiting

    2 1 1 1
    Investigated Drugs:
    • Cyclophosphamide
    • Fludarabine Phosphate
    • Rapcabtagene Autoleucel
    Austria Belgium Czechia Denmark France Germany +5
Previous Page
1 … 856 857 858 859 860 … 1,673
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!